FOXM1 and prostate carcinoma: The results indicated that FOXM1 was largely expressed in castration-sensitive prostate cancer (CSPC) circulating tumor cells (CTCs) and castration-resistant prostate cancer (CRPC) circulating tumor cells (CTCs) (Figure 9(g)).